Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Aldara activates TLR7-independent immune defence.
Walter A, Schäfer M, Cecconi V, Matter C, Urosevic-Maiwald M, Belloni B, Schönewolf N, Dummer R, Bloch W, Werner S, Beer HD, Knuth A, van den Broek M. Walter A, et al. Nat Commun. 2013;4:1560. doi: 10.1038/ncomms2566. Nat Commun. 2013. PMID: 23463003 Free article.
Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas.
Dummer R, Eichmüller S, Gellrich S, Assaf C, Dreno B, Schiller M, Dereure O, Baudard M, Bagot M, Khammari A, Bleuzen P, Bataille V, Derbij A, Wiedemann N, Waterboer T, Lusky M, Acres B, Urosevic-Maiwald M. Dummer R, et al. Mol Ther. 2010 Jun;18(6):1244-7. doi: 10.1038/mt.2010.52. Epub 2010 Apr 6. Mol Ther. 2010. PMID: 20372104 Free PMC article. Clinical Trial.
Evaluation of lymphangiogenic markers in Sézary syndrome.
Karpova MB, Fujii K, Jenni D, Dummer R, Urosevic-Maiwald M. Karpova MB, et al. Leuk Lymphoma. 2011 Mar;52(3):491-501. doi: 10.3109/10428194.2010.517877. Epub 2010 Sep 17. Leuk Lymphoma. 2011. PMID: 20846094
TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trial.
Dreno B, Urosevic-Maiwald M, Kim Y, Guitart J, Duvic M, Dereure O, Khammari A, Knol AC, Derbij A, Lusky M, Didillon I, Santoni AM, Acres B, Bataille V, Chenard MP, Bleuzen P, Limacher JM, Dummer R. Dreno B, et al. PLoS One. 2014 Feb 24;9(2):e83670. doi: 10.1371/journal.pone.0083670. eCollection 2014. PLoS One. 2014. PMID: 24586226 Free PMC article. Clinical Trial.
26 results